MedTrace Logo

Hemofilter Life Span, ECLS And/or CRRT

NCT04193865 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2024-10-28

No results posted yet for this study

Summary

The goal of this project to better understand the immune-modulatory effects of continuous renal replacement therapy (CRRT) in neonatal and pediatric patients, particularly those receiving extracorporeal life support (ECLS). Little is known about the effects of CRRT in this particular population and improved knowledge will be useful clinically and may lead to novel therapeutic approaches and improved outcomes for these critically ill patients.

Conditions

  • Kidney Diseases
  • Acute Injury of Kidney
  • Renal Failure
  • Renal Insufficiency
  • Neonatal Renal Disorder (Disorder)

Sponsors & Collaborators

  • Baxter Healthcare Corporation

    collaborator INDUSTRY

  • Medical University of South Carolina

    lead OTHER

Principal Investigators

  • Heidi Murphy, MD · Medical University of South Carolina

Eligibility

Min Age
0 Days
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-09
Primary Completion
2023-03-01
Completion
2024-03-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04193865 on ClinicalTrials.gov